AIM ImmunoTech Inc.
AIM
$0.1208
$0.00080.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.18% | -44.98% | -61.35% | -48.94% | 0.61% |
| Total Depreciation and Amortization | -31.43% | -29.23% | -9.12% | -7.03% | 25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 156.11% | 102.73% | -5.64% | -84.59% | -36.12% |
| Change in Net Operating Assets | -55.06% | 98.50% | 553.86% | 638.20% | -42.64% |
| Cash from Operations | -17.71% | -37.79% | -31.54% | -32.03% | -11.37% |
| Capital Expenditure | 97.98% | 100.00% | 100.00% | 100.00% | -235.15% |
| Sale of Property, Plant, and Equipment | -98.79% | -99.70% | -99.54% | -98.79% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.68% | 120.46% | -112.55% | -112.25% | -109.86% |
| Cash from Investing | -71.29% | -96.46% | -108.10% | -107.57% | -65.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 197.93% | 850.77% | 296.67% | 506.25% | 64.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,543.20% | 4,246.15% | 1,685.56% | 506.25% | 64.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.01% | -30.34% | -259.31% | -328.85% | -90.97% |
